Adults experiencing reduced physical sexual arousal or difficulty reaching orgasm may be prescribed Clitoris, an oral sildenafil citrate treatment intended for women. Taken before sexual activity, it…
Adults experiencing reduced physical sexual arousal or difficulty reaching orgasm may be prescribed Clitoris, an oral sildenafil citrate treatment intended for women. Taken before sexual activity, it supports blood flow to female genital tissues and may improve sensitivity, lubrication, and physical sexual response when sexual stimulation is present.
Clitoris contains sildenafil citrate, a phosphodiesterase type 5 inhibitor, also called a PDE5 inhibitor. It is intended for women whose clinician has identified a physical arousal component to sexual difficulties. Sexual stimulation remains necessary; Clitoris does not create desire on its own or guarantee orgasm.
Sildenafil citrate is the active ingredient in Clitoris. It is taken orally before planned sexual activity. The medicine acts on blood-vessel signalling rather than hormones, mood, relationship concerns, or stress-related factors.
Treatment goals can include improved physical arousal, genital sensitivity, lubrication, and orgasm response. Results vary because sexual arousal is influenced by circulation, hormonal status, current medicines, emotional wellbeing, fatigue, and relationship context.
The European Medicines Agency describes sildenafil as a PDE5 inhibitor that acts through the nitric oxide–cyclic GMP pathway in vascular tissue [1].
Clitoris may support a stronger physical arousal response where reduced genital blood flow is part of the problem. Some women report better sensitivity, easier lubrication, and improved ability to reach orgasm. These are treatment aims, not promised outcomes.
A useful result may be less noticeable when the main concern is low desire rather than physical response. Sildenafil also does not treat vaginal pain, untreated depression, relationship conflict, menopause-related hormonal change, or adverse sexual effects from another medicine.
| Treatment focus | What sildenafil may influence | What it does not directly treat |
|---|---|---|
| Physical sexual arousal | Local blood flow and sensitivity during stimulation | Emotional connection or sexual interest |
| Lubrication response | Vascular contribution to genital response | Infection, irritation, or pain disorders |
| Orgasm response | Physical responsiveness in some women | A guaranteed orgasm outcome |
Women who respond may notice greater warmth, sensitivity, lubrication, or a more sustained physical response during sexual activity. Published research on sildenafil for female sexual dysfunction has produced mixed results, with response depending on the cause of symptoms and the study population.
The International Society for the Study of Women’s Sexual Health stressed in its 2021 clinical guidance that female sexual difficulties require assessment of biological, psychological, interpersonal, and medication-related factors [2].
Persistent low arousal can arise from antidepressants, hormonal transitions, diabetes, pelvic pain, anxiety, poor sleep, or cardiovascular risk factors. Clitoris may be part of a treatment plan when vascular response is relevant, yet it does not replace investigation of these contributors.
Take Clitoris orally about 30 to 60 minutes before sexual activity. The chosen regimen must be confirmed with a healthcare professional before starting. Sildenafil begins working at different speeds between individuals, and its physical effects can persist for several hours.
Do not take an additional tablet because the first effect feels slower than expected. Extra sildenafil raises the chance of headache, dizziness, flushing, low blood pressure, and visual symptoms.
A prescriber should also assess significant heart disease, recent heart attack or stroke, low blood pressure, uncontrolled high blood pressure, severe liver impairment, severe kidney impairment, and prior serious reactions to sildenafil. Eye conditions involving reduced blood supply to the optic nerve also need individual assessment.
Do not combine Clitoris with nitrate medicines such as glyceryl trinitrate, isosorbide mononitrate, or isosorbide dinitrate. Do not use it with riociguat. Dose spacing does not make these combinations suitable.
Alpha-blockers may add to sildenafil’s blood-pressure-lowering effect. Strong CYP3A4 inhibitors, including certain antifungal medicines and some treatments for viral infections, can raise sildenafil levels in the body.
Clitoris is not for you if you use nitrate medicines for chest pain, use riociguat, or have been told that sexual activity is unsafe because of your cardiovascular condition. Combining sildenafil with nitrates or riociguat can cause a dangerous fall in blood pressure.
Sildenafil citrate can cause headache, facial flushing, indigestion, blocked nose, dizziness, and temporary visual changes. These effects are often mild, though they can interfere with plans or daily activities. Persistent or severe symptoms need prescriber review.
Some women find that a headache starts after the sexual activity has ended. Hydration and avoiding repeat doses on the same occasion can reduce avoidable discomfort.
| Symptom type | Examples | Action |
|---|---|---|
| Common effects | Headache, flushing, indigestion, nasal congestion | Rest and seek advice if persistent or troublesome |
| Effects needing review | Marked dizziness, palpitations, persistent visual disturbance | Contact the prescriber promptly |
| Urgent symptoms | Chest pain, fainting, severe allergic reaction, sudden hearing or vision loss | Seek urgent medical care |
Headache and flushing reflect sildenafil’s blood-vessel effects. Dizziness can be more likely in people with naturally low blood pressure or when alcohol is involved. Temporary colour tingeing, light sensitivity, or blurred vision can occur because PDE5 inhibitors may affect related enzymes in the eye.
Chest pain, collapse, severe breathlessness, facial swelling, wheezing, sudden loss of vision, or sudden hearing changes require urgent medical assessment. Do not take another dose while these symptoms are being assessed.
The FDA prescribing information for sildenafil lists cardiovascular symptoms, sudden visual changes, and sudden hearing changes among events requiring prompt attention [3].
Sildenafil citrate blocks PDE5, an enzyme that breaks down cyclic guanosine monophosphate, or cyclic GMP. Cyclic GMP is a chemical messenger released after nitric oxide signalling during sexual stimulation. When PDE5 is inhibited, cyclic GMP remains active for longer and local blood vessels can relax more readily.
This may increase female genital blood flow and strengthen the physical part of sexual arousal. It does not directly increase sexual desire. A woman may still have low interest in sex if the main cause is hormonal change, depression, pain, relationship distress, medication effects, or exhaustion.
PDE5 inhibition supports the body’s normal vascular response to sexual stimulation. Sildenafil does not act as an automatic trigger. The response depends on stimulation, circulation, timing, and individual sensitivity.
Physical arousal and desire are related but different. Blood-flow support may help a woman who feels mentally interested but has an inadequate physical response. It is less likely to address absent desire caused by a non-vascular factor.
How does Clitoris differ from the closest alternative by active substance or mechanism?
Clitoris uses sildenafil citrate to support blood-flow signalling through PDE5 inhibition. Other approaches for female sexual difficulties may target hormones, central nervous system pathways, pain, mood, or relationship factors instead of vascular response. The International Society for the Study of Women’s Sexual Health stated in 2021 that treatment should match the identified cause of symptoms. Sildenafil is most relevant when physical arousal response is the treatment target.
Clinicians usually begin with the pattern of symptoms: whether sexual desire is present, whether physical arousal is reduced, whether orgasm has become difficult, and when the change began. They also review blood pressure, cardiovascular history, current medicines, hormonal factors, diabetes, mood, and previous reactions to PDE5 inhibitors.
A realistic expectation matters. Clitoris may improve the physical response to stimulation, yet it cannot resolve every cause of reduced sexual satisfaction.
A clinician may ask about chest symptoms during exertion, episodes of fainting, migraine, vision changes, kidney or liver disease, and medicines used for angina or pulmonary hypertension. This assessment protects against dangerous interactions and helps identify whether sildenafil fits the symptom pattern.
The World Health Organization’s 2019 safety information on sexual health medicines supports individual assessment where cardiovascular disease or interacting treatment is present [4].
Clitoris is generally used before planned sexual activity rather than as a fixed daily course. Longer-term use depends on continued suitability, blood-pressure tolerance, current medicines, and whether the original symptom pattern remains the same. The EMA’s 2024 sildenafil product information supports periodic clinical review when treatment is ongoing, especially where cardiovascular health or interacting medicines may change [5]. A prescriber should reassess persistent symptoms rather than simply increasing use. Follow-up can also identify changes in cardiovascular health or interacting medicines.
Age alone does not rule out Clitoris. Women aged over 65 may be more likely to use blood-pressure medicines, nitrates, alpha-blockers, or treatments that interact with sildenafil, so medication review is essential. The HPRA advises that prescribing decisions should account for cardiovascular status, kidney function, liver function, and concurrent medicines. In 2026, those checks remain more relevant than age alone.
A lighter meal may support more predictable timing because a high-fat meal can delay sildenafil absorption. Regular movement, smoking cessation, sleep, and management of diabetes or blood pressure can support vascular health, which is relevant to physical arousal. WHO guidance published in 2023 links cardiovascular risk reduction with better vascular health across adulthood. Heavy alcohol use can hinder response and increase dizziness.
Alcohol can add to dizziness, flushing, low blood pressure, and impaired judgement. It may also reduce sexual responsiveness, making it harder to tell whether Clitoris is helping. The FDA’s 2023 sildenafil prescribing information advises caution where blood-pressure effects may be amplified. Avoiding alcohol around the first few uses gives a clearer picture of personal tolerance.
Clitoris uses sildenafil citrate to support blood-flow signalling through PDE5 inhibition. Other approaches for female sexual difficulties may target hormones, central nervous system pathways, pain, mood, or relationship factors instead of vascular response. The International Society for the Study of Women’s Sexual Health stated in 2021 that treatment should match the identified cause of symptoms. Sildenafil is most relevant when physical arousal response is the treatment target.
Discuss chest pain, heart disease, low blood pressure, a recent heart attack or stroke, eye disease, kidney or liver disease, and any previous reaction to sildenafil. List every medicine, with special attention to nitrates, riociguat, alpha-blockers, antifungal medicines, and antiviral treatments. The EMA’s 2024 product information identifies nitrates and riociguat as combinations that must be avoided. Mention whether low arousal began after starting an antidepressant, hormonal treatment, or blood-pressure medicine.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Based on 5 reviews
I used Clitoris before planned intimacy on three occasions. The first time I had eaten a large evening meal and felt the effect took longer. On the next attempt, timing was better and I noticed more physical sensitivity, though I did get a mild headache afterwards.
Three occasions 7 Oct 2026I took it about an hour beforehand. It did not change my desire, but it helped the physical side once I was already relaxed and interested. I had flushing for around half an hour, which was manageable.
16 Oct 2026The tablet did not give the result I expected at first. My doctor later reviewed other medicines I was taking and explained that my symptoms were not only about blood flow. I stopped treating it as a quick fix.
21 Oct 2026I discussed my blood pressure medicines before trying Clitoris. I did not use it until my prescriber confirmed the combination was suitable. The response was subtle, but I felt less dryness and more comfort during intimacy.
30 Oct 2026I had dizziness after taking it with wine, so I did not repeat that combination. When I used it another time without alcohol, the experience was better. It helped physical arousal, though it did not solve stress-related low interest.
3 Nov 2026
